NASDAQ:NKGNW

NKGen Biotech (NKGNW) Stock Price, News & Analysis

$0.0002 0.00 (0.00%)
As of 11/6/2026

About NKGen Biotech Stock (NASDAQ:NKGNW)

Advanced

Key Stats

Today's Range
$0.0002
▼
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.11
Volume
N/A
Average Volume
211,125 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NKGen Biotech is a clinical-stage biotechnology company developing natural killer (NK) cell therapies for cancer and neurodegenerative diseases. Its research focuses on expanding and activating NK cells, immune cells that can identify and attack abnormal cells.

The company’s lead candidate, SNK01, is an autologous, non-genetically modified NK cell therapy made from a patient’s own cells. NKGen has investigated SNK01 in clinical programs involving Alzheimer’s disease and cancer. Its work also includes developing additional NK cell therapy candidates.

NKGen is based in Santa Ana, California. Paul Song, M.D., has served as the company’s chief executive officer.

AI Generated. May Contain Errors.

Receive NKGNW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NKGNW Stock News Headlines

Last call for your free 0DTE report
The 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for $29.97, but it's available as a free download for a limited time.tc pixel
NKGen Biotech Secures New Promissory Note Financing
NKGen Biotech Secures $2.5M in Stock Purchase Agreement
See More Headlines

NKGNW Stock Analysis - Frequently Asked Questions

NKGen Biotech's stock was trading at $0.0001 on February 19, 2026. Since then, NKGNW shares have increased by 100.0% and is now trading at $0.0002.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:NKGNW
CIK
1845459
Fax
N/A
Employees
63
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NASDAQ:NKGNW) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners